Puma Biotechnology, Inc.
USD8.14
-0.05 (-0.61%)
CEO
Alan H. Auerbach
IPO Date
2012-04-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.11
Prev. Close
$8.19
Day Low
$8.11
Day High
$8.25
52W Low
$3.03
52W High
$8.41
Market Cap
$0.41B
Volume
0.09M
| 4.9 |
| 31 Dec 2023 | FY | 73.4% | 9.2% | 40.4% | 9.4% | 2.09 | 1.57 | 9.5 |
| 31 Dec 2022 | FY | 75.8% | 0.0% | 0.0% | 0.0% | 5.29 | 1.73 | 94486.6 |
| 31 Dec 2021 | FY | 74.8% | -11.5% | 1190.8% | -12.9% | -47.69 | 1.28 | -4.2 |
| 31 Dec 2020 | FY | 82.5% | -26.7% | 1008.1% | -24.6% | -20.32 | 1.28 | -6.8 |
| 31 Dec 2019 | FY | 86.5% | -27.8% | -432.9% | -32.2% | 6.88 | 1.83 | -4.5 |
| 31 Dec 2018 | FY | 86.2% | -45.3% | -331.1% | -43.8% | 4.43 | 3.02 | -6.8 |
| 31 Dec 2017 | FY | 79.8% | -1054.2% | -547.8% | -176.4% | 0.91 | 1.82 | -12.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -131.6% | -109.2% | 0.00 | 6.31 | -3.7 |
| 5.6 |
| 30 Sept 2025 | Q3 | 77.7% | 16.2% | 7.7% | 4.4% | 0.36 | 1.74 | 7.6 |
| 30 Jun 2025 | Q2 | 76.5% | 11.2% | 5.6% | 3.0% | 0.47 | 1.73 | 7.3 |
| 31 Mar 2025 | Q1 | 77.1% | 6.5% | 3.1% | 1.5% | 0.64 | 1.53 | 12.3 |
| 31 Dec 2024 | Q4 | 76.4% | 32.7% | 21.0% | 9.0% | 0.80 | 1.54 | 1.9 |
| 30 Sept 2024 | Q3 | 63.9% | 25.2% | 28.6% | 9.2% | 1.21 | 1.42 | 1.5 |
| 30 Jun 2024 | Q2 | 77.4% | -9.6% | -9.3% | -2.2% | 2.03 | 1.32 | -8.7 |
| 31 Mar 2024 | Q1 | 75.5% | -11.0% | -9.4% | -2.2% | 2.17 | 1.46 | -13.2 |
| 31 Dec 2023 | Q4 | 66.3% | 17.0% | 23.0% | 5.3% | 2.09 | 1.57 | 4.2 |